Abstract
This study aimed at determining the prevalence of falling in PD patients, to assess generic and disease-specific clinical and pharmacological factors, relationship with health-related quality of life (HR-QoL) and changes in falls from OFF to ON in patients with motor fluctuations. Six-hundred and eighty-three PD patients of the COPARK survey were evaluated (11 had missing data and were excluded from the analysis). Patients with falls were identified as those with a UPDRS Item 13 ≥ 1 in the ON condition. All patients were assessed in a standardized manner [demographics, treatments, Unified PD Rating Scale (UPDRS), Hospital Anxiety and Depression Scale, Pittsburg questionnaire and HR-QoL scales (SF36, PDQ39)]. Falling was reported by 108/672 (16 %) PD patients during the ON state and prevalence increased according to PD severity, from 5 % in Hoehn and Yahr stage 1–60 % in stage 4. Falling was significantly related to lower HR-QoL. Falling correlated with (1) generic factors such as female gender, age at the end of academic studies and diuretics consumption, (2) motor PD-specific factors including disease severity, frozen gait, difficulties when arising from a chair, dyskinesia and higher levodopa daily equivalent dose and (3) non-motor PD-specific factors such as orthostatic hypotension and hallucinations. Falling was more frequent in OFF than in ON in 48/74 (64 %) patients with motor fluctuations and remained unchanged in 27 patients (36 %). In summary, falling affected a significant proportion of PD patients, especially in advanced stages. It was associated with a variety of generic and PD-specific factors and was related to reduced HR-QoL.
Similar content being viewed by others
References
Allen NE, Schwarzel AK, Canning CG (2013) Recurrent falls in Parkinson’s disease: a systematic review. Parkinsons Dis 2013:906274. doi:10.1155/2013/906274
Bloem BR, Hausdorff JM, Visser JE, Giladi N (2004) Falls and freezing of gait in Parkinson’s disease: a review of two interconnected, episodic phenomena. Mov Disord 19(8):871–884. doi:10.1002/mds.20115
Burrows S, Auger N, Gamache P, Hamel D (2012) Individual and area socioeconomic inequalities in cause-specific unintentional injury mortality: 11-year follow-up study of 2.7 million Canadians. Accid Anal Prev 45:99–106. doi:10.1016/j.aap.2011.11.010
Cheng KY, Lin WC, Chang WN, Lin TK, Tsai NW, Huang CC, Wang HC, Huang YC, Chang HW, Lin YJ, Lee LH, Cheng BC, Kung CT, Chang YT, Su CM, Chiang YF, Su YJ, Lu CH (2014) Factors associated with fall-related fractures in Parkinson’s disease. Parkinsonism Relat Disord 20(1):88–92. doi:10.1016/j.parkreldis.2013.09.024
Clubb VJ, Clubb SE, Buckley S (2006) Parkinson’s disease patients who fracture their neck of femur: a review of outcome data. Injury 37(10):929–934. doi:10.1016/j.injury.2005.11.013
Coelho M, Marti MJ, Tolosa E, Ferreira JJ, Valldeoriola F, Rosa M, Sampaio C (2010) Late-stage Parkinson’s disease: the Barcelona and Lisbon cohort. J Neurol 257(9):1524–1532. doi:10.1007/s00415-010-5566-8
Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N (2008) Movement disorder society-sponsored revision of the unified Parkinson’s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23(15):2129–2170
Hiorth YH, Lode K, Larsen JP (2013) Frequencies of falls and associated features at different stages of Parkinson’s disease. Eur J Neurol 20(1):160–166. doi:10.1111/j.1468-1331.2012.03821.x
Jenkinson C, Peto V, Fitzpatrick R, Greenhall R, Hyman N (1995) Self-reported functioning and well-being in patients with Parkinson’s disease: comparison of the short-form health survey (SF-36) and the Parkinson’s Disease Questionnaire (PDQ-39). Age Ageing 24(6):505–509
Kerr GK, Worringham CJ, Cole MH, Lacherez PF, Wood JM, Silburn PA (2010) Predictors of future falls in Parkinson disease. Neurology 75(2):116–124. doi:10.1212/WNL.0b013e3181e7b688
Matinolli M, Korpelainen JT, Korpelainen R, Sotaniemi KA, Myllyla VV (2009) Orthostatic hypotension, balance and falls in Parkinson’s disease. Mov Disord 24(5):745–751. doi:10.1002/mds.22457
Matinolli M, Korpelainen JT, Sotaniemi KA, Myllyla VV, Korpelainen R (2011) Recurrent falls and mortality in Parkinson’s disease: a prospective two-year follow-up study. Acta Neurol Scand 123(3):193–200. doi:10.1111/j.1600-0404.2010.01386.x
Michalowska M, Fiszer U, Krygowska-Wajs A, Owczarek K (2005) Falls in Parkinson’s disease. Causes and impact on patients’ quality of life. Funct Neurol 20(4):163–168
Nemanich ST, Duncan RP, Dibble LE, Cavanaugh JT, Ellis TD, Ford MP, Foreman KB, Earhart GM (2013) Predictors of gait speeds and the relationship of gait speeds to falls in men and women with Parkinson disease. Parkinsons Dis 2013:141720. doi:10.1155/2013/141720
Okuma Y (2014) Proceedings of MDPD 2013 freezing of gait and falls in Parkinson’s disease. J Parkinsons Dis 4(2):255–260. doi:10.3233/jpd-130282
Perez-Lloret S, Rey MV, Fabre N, Ory F, Spampinato U, Senard JM, Pavy-Le Traon A, Montastruc JL, Rascol O (2012) Factors related to orthostatic hypotension in Parkinson’s disease. Parkinsonism Relat Disord 18(5):501–505. doi:10.1016/j.parkreldis.2012.01.012
Perez-Lloret S, Negre-Pages L, Damier P, Delval A, Derkinderen P, Destee A, Meissner WG, Schelosky L, Tison F, Rascol O (2014) Freezing of gait in parkinson’s disease: prevalence, determinants, and effects on quality of life. JAMA Neurol 71(7):884–890
Pickering RM, Grimbergen YA, Rigney U, Ashburn A, Mazibrada G, Wood B, Gray P, Kerr G, Bloem BR (2007) A meta-analysis of six prospective studies of falling in Parkinson’s disease. Mov Disord 22(13):1892–1900. doi:10.1002/mds.21598
Revilla FJ, Larsh TR, Mani A, Duker AP, Cox C, Succop P, Gartner M, Jarrin Tejada C, Bhattacharya A (2013) Effect of dopaminergic medication on postural sway in advanced Parkinson’s disease. Front Neurol 4:202. doi:10.3389/fneur.2013.00202
Rossi-Izquierdo M, Basta D, Rubio-Rodriguez JP, Santos-Perez S, Ernst A, Sesar-Ignacio A, Alberte-Woodward M, Amo MG, Estany-Gestal A, Roman-Rodriguez ES, Faraldo-Garcia A, Zubizarreta-Gutierrez A, Soto-Varela A (2014) Is posturography able to identify fallers in patients with Parkinson’s disease? Gait Posture. doi:10.1016/j.gaitpost.2014.02.003
Rudzinska M, Bukowczan S, Stozek J, Zajdel K, Mirek E, Chwala W, Wojcik-Pedziwiatr M, Banaszkiewicz K, Szczudlik A (2013) The incidence and risk factors of falls in Parkinson disease: prospective study. Neurol Neurochir Pol 47(5):431–437
Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653. doi:10.1002/mds.23429
van der Marck MA, Klok MP, Okun MS, Giladi N, Munneke M, Bloem BR (2013) Consensus-based clinical practice recommendations for the examination and management of falls in patients with Parkinson’s disease. Parkinsonism Relat Disord. doi:10.1016/j.parkreldis.2013.10.030
Voss TS, Elm JJ, Wielinski CL, Aminoff MJ, Bandyopadhyay D, Chou KL, Sudarsky LR, Tilley BC (2012) Fall frequency and risk assessment in early Parkinson’s disease. Parkinsonism Relat Disord 18(7):837–841. doi:10.1016/j.parkreldis.2012.04.004
Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–483
Wood BH, Bilclough JA, Bowron A, Walker RW (2002) Incidence and prediction of falls in Parkinson’s disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry 72(6):721–725
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370
Acknowledgments
The authors thank the patients who agreed to participate in this study and the Association France-Parkinson for its support. The project was co-funded by unrestricted and unconditional grants from the Association France-Parkinson, ADREN, Boehringer Ingelheim, Eisai, Faust Pharmaceuticals, GlaxoSmithKline, Pierre Fabre Médicaments, Solvay Pharma, Wyeth Lederlé. The project was sponsored and co-financed by LN PHARMA, which participated into the design and conduct of the study; collection, management, and interpretation of the data; and preparation and review of the manuscript.
Conflict of interest
Olivier Rascol reports no disclosures, Santiago Perez-Lloret reports no disclosures, Philippe Damier reports no disclosures, Arnaud Delval reports no disclosures, Pascal Derkinderen reports no disclosures, Alain Destée reports no disclosures, Wassilios Meissner reports that a grant was received by the Bordeaux University Hospital for the project. Francois Tison reports no disclosures, Laurence Negre-Pages reports grants from the Association France-Parkinson, ADREN, Boehringer Ingelheim, Eisai, Faust Pharmaceuticals, GlaxoSmithKline, Pierre Fabre Médicaments, Solvay Pharma, Wyeth Lederlé for funding this project and that she owns stock options from LN PHARMA, which was one of the sponsors of this study.
Author information
Authors and Affiliations
Corresponding author
Appendix: List of the French neurologists who participated into the patients’ selection and data collection
Appendix: List of the French neurologists who participated into the patients’ selection and data collection
Author | Degree | Affiliation |
---|---|---|
F. Tison | MD | University Hospital Bordeaux |
W. G. Meissner | MD | University Hospital Bordeaux |
U. Spampinato | MD | University Hospital Bordeaux |
P. Damier | MD | University Hospital Nantes |
P. Derkinderen | MD | University Hospital Nantes |
O. Rascol | MD | University Hospital Toulouse |
V. Rey-Zermati | MD | General Hospital Narbonne |
X. Soulages | MD | General hospital Rodez |
C. Azais-Vuillemin | MD | Clinique du Parc, Toulouse |
N. Stambouli | MD | General Hospital, Cahors |
J. R. Rouane | MD | Clinique Pasteur, Toulouse |
A. M. Salandini | MD | Clinique Pasteur, Toulouse |
J. M. Boulesteix | MD | General Hospital, Cahors |
M. Barreda | MD | Clinique Toulouse Lautrec, Castres |
D. Castan | MD | General Hospital Castres |
A. Ojero-Senard | MD | University Hospital Toulouse |
S. Perez-Lloret | MD | University Hospital Toulouse |
G. Angibaud | MD | Clinique pont-de-Chaume, Montauban |
J. P. Balague | MD | Clinique pont-de-Chaume, Montauban |
A. Danielli | MD | Hopital General, Montauban |
N. Attane | MD | Hopital Général, Carcasonne |
J. M. Faucheux | MD | Hopital Général, Castres |
P. Henry | MD | Clinique Ambroise Paré, Toulouse |
M.H Rougie | MD | Private Office Toulouse |
B. Jardillier | MD | General hospital Figeac |
F Azais | MD | Private Office, Toulouse |
L Damase | MD | Private Office, Toulouse |
A. Destee | MD | University Hospital Lille |
P. Lejeune | MD | Hopital Départemental La- Roche-sur-Yon |
JM Delabrousse-Mayoux | MD | Private Office, Bergerac |
S. Bonenfant | BSc | University Hospital Toulouse |
R. Darmanaden | MD | Hopital Général, Villefranche de Rouergue |
A. Robinson | MD | Hopital Général, Carcasonne |
E. Gaujard | MD | Private Office, Bordeaux |
E. Puymirat | MD | Clinique saint-Augustin, Bordeaux |
C. E. Goumard | MD | Private Office, Bordeaux |
M. H. Godin | MD | Private Office, Bordeaux |
C. Latxague | PhD | University of Bordeaux |
C. Deligny | MD | Private practice, Nantes |
T. Lebouvier | MD | University Hospital Nantes |
C. Lanctin-Garcia | MD | Private practice, Nantes |
M. Roy | BSc | University Hospital Nantes |
V. Verbist-Talmant | MD | University Hospital Nantes |
P. Bertout | MD | Private practice, Saint Nazaire |
Rights and permissions
About this article
Cite this article
Rascol, O., Perez-Lloret, S., Damier, P. et al. Falls in ambulatory non-demented patients with Parkinson’s disease. J Neural Transm 122, 1447–1455 (2015). https://doi.org/10.1007/s00702-015-1396-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-015-1396-2